Document is current
Any future updates will be listed below
-
Authors
Wicker, Alexandra
Shriram, Jahnavi
Decourt, Boris
Sabbagh, Marwan Noel
- License Information
-
More Information
Article History
Received: 7 August 2024
Accepted: 16 September 2024
First Online: 8 October 2024
Declarations
:
: Alexandra Wicker, Jahnavi Shriram, and Boris Decourt have nothing to disclose. Marwan Sabbagh is an Editor-in-Chief of <i>Neurology and Therapy</i>. Marwan Sabbagh was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Dr Sabbagh discloses Consulting: Roche-Genentech, Eisai, Lilly, Synaptogenix, NeuroTherapia, Signant Health, Novo Nordisk, Prothena, Anavex, Cognito Therapeutics, GSK, Abbvie and Board of Director: EIP Pharma/CervoMed.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Since it is a narrative review, IRB or ethical approval was not necessary.
